Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Von Willebrand Factor Propeptide and Pathophysiological Mechanisms in European and Iranian Patients With Type 3 Von Willebrand Disease Enrolled in the 3Winters-Ips Study Publisher Pubmed



Pagliari MT1 ; Rosendaal FR2 ; Ahmadinejad M3, 4 ; Badiee Z5 ; Baghaipour MR6 ; Baronciani L7 ; Benitez Hidalgo O8 ; Bodo I9 ; Budde U10 ; Castaman G11 ; Eshghi P4 ; Goudemand J12 ; Karimi M13 ; Keikhaei B14 Show All Authors
Authors
  1. Pagliari MT1
  2. Rosendaal FR2
  3. Ahmadinejad M3, 4
  4. Badiee Z5
  5. Baghaipour MR6
  6. Baronciani L7
  7. Benitez Hidalgo O8
  8. Bodo I9
  9. Budde U10
  10. Castaman G11
  11. Eshghi P4
  12. Goudemand J12
  13. Karimi M13
  14. Keikhaei B14
  15. Lassila R15
  16. Leebeek FWG16
  17. Lopez Fernandez MF17
  18. Mannucci PM7
  19. Marino R18
  20. Oldenburg J19
  21. Peake I20
  22. Santoro C21
  23. Schneppenheim R22
  24. Tiede A23
  25. Toogeh G24
  26. Tosetto A25
  27. Trossaert M26
  28. Yadegari H19
  29. Zetterberg EMK27
  30. Peyvandi F7, 28
  31. Federici AB29
  32. Eikenboom J30

Source: Journal of Thrombosis and Haemostasis Published:2022


Abstract

Background: Type 3 von Willebrand disease (VWD) is a severe bleeding disorder caused by the virtually complete absence of von Willebrand factor (VWF). Pathophysiological mechanisms of VWD like defective synthesis, secretion, and clearance of VWF have previously been evaluated using ratios of VWF propeptide (VWFpp) over VWF antigen (VWF:Ag) and factor (F)VIII coagulant activity (FVIII:C) over VWF:Ag. Objective: To investigate whether the VWFpp/VWF:Ag and FVIII:C/VWF:Ag ratios may also be applied to understand the pathophysiological mechanism underlying type 3 VWD and whether VWFpp is associated with bleeding severity. Methods: European and Iranian type 3 patients were enrolled in the 3WINTERS-IPS study. Plasma samples and buffy coats were collected and a bleeding assessment tool was administered at enrolment. VWF:Ag, VWFpp, FVIII:C, and genetic analyses were performed centrally, to confirm patients’ diagnoses. VWFpp/VWF:Ag and FVIII:C/VWF:Ag ratios were compared among different variant classes using the Mann-Whitney test. Median differences with 95% confidence intervals (CI) were estimated using the Hodges-Lehmann method. VWFpp association with bleeding symptoms was assessed using Spearman’s rank correlation. Results: Homozygosity/compound heterozygosity for missense variants showed higher VWFpp level and VWFpp/VWF:Ag ratio than homozygosity/compound heterozygosity for null variants ([VWFpp median difference, 1.4 IU/dl; 95% CI, 0.2–2.7; P =.016]; [VWFpp/VWF:Ag median difference, 1.4; 95% CI, 0–4.2; P =.054]). FVIII:C/VWF:Ag ratio was similarly increased in both. VWFpp level did not correlate with the bleeding symptoms (r =.024; P =.778). Conclusions: An increased VWFpp/VWF:Ag ratio is indicative of missense variants, whereas FVIII:C/VWF:Ag ratio does not discriminate missense from null alleles. The VWFpp level was not associated with the severity of bleeding phenotype. © 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.
Other Related Docs
6. Bleeding Disorder of Unknown Cause: Results From Iranian Study, Transfusion and Apheresis Science (2023)
18. Evaluation of Some Plasma Coagulation Factors in Women With Spontaneous Miscarriage, International Journal of Fertility and Sterility (2015)